The Union has launched the IJTLD Clinical Standards for Lung Health to help clinicians manage and treat patients with respiratory diseases.
A Standard prescribes a widely accepted level of diagnosis and care, which guides all healthcare providers and clinicians in achieving optimal management of patients who have, or are suspected of having, a given disease.
Until now, Clinical Standards have not been available for specific aspects of TB, or other respiratory diseases.
We have now addressed this important gap in the literature with the launch – in the October issue of the International Journal of Tuberculosis and Lung Disease – of the IJTLD Clinical Standards for Lung Health.
Working with a panel of global experts, representing the main societies, associations and groups active in the field, we have assessed the relevant issues and defined the Clinical Standards for the assessment, management and rehabilitation of post-TB lung disease.
Also, thanks to the support of the Oskar-Helene-Heim Foundation and the Günther Labes Foundation, the first four Clinical Standards have been made Open Access and freely available to our global audience of clinicians for optimal disease management and patient care. There will also be an Introduction to the IJTLD Clinical Standards on PTLD and LTBI at the 52nd Union World Conference on Lung Health on Wednesday 20th October from 16:00–17:00 (CET).
Other Clinical Standards will follow to cover COVID-19 and other respiratory diseases.
The first Clinical Standard and the accompanying Editorial are free to read in the October issue of the IJTLD.